Stocks · US
HIMS
XNYS
Hims & Hers Health, Inc.
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-06 basis
P/E—
P/B21.36x
P/S2.69x
EPS$-0.61
ROE-43.83%
ROA-3.91%
Dividend yield0.00%
Debt/Equity4.21
Free cash flow$74M
Returns and 52-week range
1W+2.68%
1M+6.35%
3M-18.30%
6M+51.13%
1Y-43.91%
YTD-11.79%
52W high$65.30
52W low$13.74
From 52W high-54.87%
Company
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| 오스카 헬스 | $10.0B | 18.17 | 4.88 | +0.28% |
| 노보노디스크(ADR) | — | — | — | -19.46% |
| The Ensign Group, Inc. | $10.1B | 26.61 | 4.13 | +0.74% |
| 바이오엔테크(ADR) | — | — | — | -7.74% |
| 몰리나 헬스케어 | $10.1B | — | 2.43 | -2.80% |
| Bio-Rad Laboratories, Inc.Class A | $10.2B | 45.66 | 1.42 | -4.48% |
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.